Skip to content

Castor EDC to Sponsor ACDM19

Date: January 15, 2019

The Association for Clinical Data Management (ACDM) are delighted to announce that Castor EDC are to be the Communications Sponsor and exhibitor of ACDM19.

Built by researchers, for researchers, Castor EDC is a user-friendly cloud solution for capturing medical research data in clinical trials. Features include self-service eCRF creation (form building), randomization, ePro (patient surveys), monitoring, easy import and export of data, EHR data importer (HL7 FHIR based), audit trails, user management, and much more. Castor is ISO 27001 certified, GCP, 21 CFR & GDPR compliant and provides servers in the US (HIPAA compliant), the Netherlands and the United Kingdom.

Click for Website

 

 


 

Explore More News

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available

The ICH Working Groups and The ICH Training Associates have released two new training . . .

Read More

Recent update from the regulatory landscape in clinical data management

On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .

Read More

Regulatory Considerations DMEG Update – August 2026

Please read the following update from the Regulatory Considerations DMEG:  July and . . .

Read More

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .

Read More

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG

Health Canada (HC) continues to publish new guidelines to support their modernization of . . .

Read More

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Read More

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Read More

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG:  Regulators have . . .

Read More

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Read More

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Read More

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Read More

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .

Read More